Ultralife (ULBI) Invested Capital (2010 - 2026)

Ultralife's Invested Capital history runs 17 years deep, the most recent figure standing at $133.1 million for Q1 2026.

• In Q1 2026, Invested Capital fell 4.75% year-over-year to $133.1 million; the TTM figure through Mar 2026 stood at $133.1 million (down 4.75% YoY), while the FY2025 annual figure was $134.3 million, down 1.96% from the prior year.
• Invested Capital was $133.1 million for Q1 2026 at Ultralife, down from $134.3 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $142.1 million in Q2 2025 to a low of $117.3 million in Q3 2022.
• Historically, Invested Capital has averaged $129.2 million across 5 years, with a median of $130.9 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Invested Capital climbed 11.23% in 2024, then decreased 4.75% in 2026.
• A 5-year view of Invested Capital shows it stood at $118.3 million in 2022, then rose by 7.74% to $127.4 million in 2023, then gained by 7.46% to $136.9 million in 2024, then decreased by 1.96% to $134.3 million in 2025, then retreated by 0.89% to $133.1 million in 2026.
• The last three Invested Capital figures came in at $133.1 million (Q1 2026), $134.3 million (Q4 2025), and $141.2 million (Q3 2025), per Business Quant data.